33 related articles for article (PubMed ID: 32649753)
1. Dynamic network biomarker indicates pulmonary metastasis at the tipping point of hepatocellular carcinoma.
Yang B; Li M; Tang W; Liu W; Zhang S; Chen L; Xia J
Nat Commun; 2018 Feb; 9(1):678. PubMed ID: 29445139
[TBL] [Abstract][Full Text] [Related]
2. HOXD3 promotes the migration and angiogenesis of hepatocellular carcinoma via modifying hepatocellular carcinoma cells exosome-delivered CCR6 and regulating chromatin conformation of CCL20.
Wang L; Qiao C; Han L; Wang X; Miao J; Cao L; Huang C; Wang J
Cell Death Dis; 2024 Mar; 15(3):221. PubMed ID: 38493218
[TBL] [Abstract][Full Text] [Related]
3. Genkwadaphnin inhibits growth and invasion in hepatocellular carcinoma by blocking DHCR24-mediated cholesterol biosynthesis and lipid rafts formation.
Wu J; Guo L; Qiu X; Ren Y; Li F; Cui W; Song S
Br J Cancer; 2020 Nov; 123(11):1673-1685. PubMed ID: 32958824
[TBL] [Abstract][Full Text] [Related]
4. The scent fingerprint of hepatocarcinoma: in-vitro metastasis prediction with volatile organic compounds (VOCs).
Amal H; Ding L; Liu BB; Tisch U; Xu ZQ; Shi DY; Zhao Y; Chen J; Sun RX; Liu H; Ye SL; Tang ZY; Haick H
Int J Nanomedicine; 2012; 7():4135-46. PubMed ID: 22888249
[TBL] [Abstract][Full Text] [Related]
5. Aberrant LYZ expression in tumor cells serves as the potential biomarker and target for HCC and promotes tumor progression via csGRP78.
Gu Z; Wang L; Dong Q; Xu K; Ye J; Shao X; Yang S; Lu C; Chang C; Hou Y; Zhai Y; Wang X; He F; Sun A
Proc Natl Acad Sci U S A; 2023 Jul; 120(29):e2215744120. PubMed ID: 37428911
[TBL] [Abstract][Full Text] [Related]
6. CD109 regulates in vivo tumor invasion in lung adenocarcinoma through TGF-β signaling.
Taki T; Shiraki Y; Enomoto A; Weng L; Chen C; Asai N; Murakumo Y; Yokoi K; Takahashi M; Mii S
Cancer Sci; 2020 Dec; 111(12):4616-4628. PubMed ID: 33007133
[TBL] [Abstract][Full Text] [Related]
7. pIgR: frenemy of inflammation, EMT, and HCC progression.
Sphyris N; Mani SA
J Natl Cancer Inst; 2011 Nov; 103(22):1644-5. PubMed ID: 22025623
[No Abstract] [Full Text] [Related]
8. Recombinant humanized Fab fragments targeting the CFC domain of human Cripto-1.
Sandomenico A; Selis F; Sivaccumar JP; Olimpieri P; Iaccarino E; Cicatiello V; Cantile M; Sanna R; Leonardi A; De Falco S; Ruvo M
Biochem Biophys Res Commun; 2024 Jan; 694():149417. PubMed ID: 38150919
[TBL] [Abstract][Full Text] [Related]
9. Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus.
Wang XH; Liao B; Hu WJ; Tu CX; Xiang CL; Hao SH; Mao XH; Qiu XM; Yang XJ; Yue X; Kuang M; Peng BG; Li SQ
Oncologist; 2020 Oct; 25(10):e1552-e1561. PubMed ID: 32663354
[TBL] [Abstract][Full Text] [Related]
10. Deep Learning Radiomics Based on Contrast-Enhanced Ultrasound Might Optimize Curative Treatments for Very-Early or Early-Stage Hepatocellular Carcinoma Patients.
Liu F; Liu D; Wang K; Xie X; Su L; Kuang M; Huang G; Peng B; Wang Y; Lin M; Tian J; Xie X
Liver Cancer; 2020 Aug; 9(4):397-413. PubMed ID: 32999867
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal radiomics algorithm of posttreatment computed tomography images for early detecting recurrence of hepatocellular carcinoma after resection or ablation.
Shen JX; Zhou Q; Chen ZH; Chen QF; Chen SL; Feng ST; Li X; Wu TF; Peng S; Kuang M
Transl Oncol; 2021 Jan; 14(1):100866. PubMed ID: 33074127
[TBL] [Abstract][Full Text] [Related]
12. A Novel Artificially Humanized Anti-Cripto-1 Antibody Suppressing Cancer Cell Growth.
Ishii H; Zahra MH; Takayanagi A; Seno M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567764
[TBL] [Abstract][Full Text] [Related]
13. CELF1 Selectively Regulates Alternative Splicing of DNA Repair Genes Associated With Cataract in Human Lens Cell Line.
Xiao J; Jin S; Wang X; Huang J; Zou H
Biochem Genet; 2023 Aug; 61(4):1319-1333. PubMed ID: 36585568
[TBL] [Abstract][Full Text] [Related]
14. Whence CRIPTO: The Reemergence of an Oncofetal Factor in 'Wounds' That Fail to Heal.
Freeman DW; Rodrigues Sousa E; Karkampouna S; Zoni E; Gray PC; Salomon DS; Kruithof-de Julio M; Spike BT
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576327
[TBL] [Abstract][Full Text] [Related]
15. Liver-specific over-expression of Cripto-1 in transgenic mice promotes hepatocyte proliferation and deregulated expression of hepatocarcinogenesis-related genes and signaling pathways.
Liu Y; Li YQ; Huang SH; Li YL; Xia JW; Jia JS; Wei F; Wang JH; Dai GQ; Wang YC; Li XY; Han LX; Zhang XL; Xiang XD; Zhao WT; Xiao D; Lin XL
Aging (Albany NY); 2021 Sep; 13(17):21155-21190. PubMed ID: 34517344
[TBL] [Abstract][Full Text] [Related]
16. Cripto-1 promotes tumor invasion and predicts poor outcomes in hepatocellular carcinoma.
Huang T; Guo YZ; Yue X; Zhang GP; Zhang Y; Kuang M; Peng BG; Li SQ
Carcinogenesis; 2020 Jul; 41(5):571-581. PubMed ID: 32649753
[TBL] [Abstract][Full Text] [Related]
17. Cripto-1 promotes tumor invasion and predicts poor outcomes in hepatocellular carcinoma.
Huang T; Guo YZ; Yue X; Zhang GP; Zhang Y; Kuang M; Peng BG; Li SQ
Carcinogenesis; 2020 Jul; 41(5):571-581. PubMed ID: 32648918
[TBL] [Abstract][Full Text] [Related]
18. CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma.
Karkampouna S; van der Helm D; Gray PC; Chen L; Klima I; Grosjean J; Burgmans MC; Farina-Sarasqueta A; Snaar-Jagalska EB; Stroka DM; Terracciano L; van Hoek B; Schaapherder AF; Osanto S; Thalmann GN; Verspaget HW; Coenraad MJ; Kruithof-de Julio M
J Pathol; 2018 Jul; 245(3):297-310. PubMed ID: 29604056
[TBL] [Abstract][Full Text] [Related]
19. Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway.
Lo RC; Leung CO; Chan KK; Ho DW; Wong CM; Lee TK; Ng IO
Cell Death Differ; 2018 Aug; 25(8):1426-1441. PubMed ID: 29445127
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
